ResearcherWuhan Union HospitalActive in the last 2 years

Tao Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5121718719. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Last author DOI 10.18632/oncotarget.28806 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Zhou · 1 shared paper, 2025 · strength 0.27
- Paper Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. DOI 10.18632/oncotarget.28806 ↗
Shanmiao Gou · 1 shared paper, 2025 · strength 0.27
- Paper Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. DOI 10.18632/oncotarget.28806 ↗
Chunyou Wang · 1 shared paper, 2025 · strength 0.27
- Paper Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. DOI 10.18632/oncotarget.28806 ↗
Haijiao Yan · 1 shared paper, 2025 · strength 0.27
- Paper Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. DOI 10.18632/oncotarget.28806 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.